These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Putting Cartagena into practice. Watanabe KN; Taeb M; Okusu H Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448 [No Abstract] [Full Text] [Related]
47. Whither agbiotechnology? Val Giddings L Nat Biotechnol; 2006 Mar; 24(3):274-6. PubMed ID: 16525385 [No Abstract] [Full Text] [Related]
48. Genetic engineering and biotechnology, the future of making drugs? Folkers G Pharm Acta Helv; 1994 Jul; 69(1):1. PubMed ID: 7938071 [No Abstract] [Full Text] [Related]
49. Clone on the range: What animal biotech is bringing to the table. Dove AW Nat Biotechnol; 2005 Mar; 23(3):283-5. PubMed ID: 15765075 [No Abstract] [Full Text] [Related]
50. GM giants pair up to do battle. Mitchell P Nat Biotechnol; 2007 Jul; 25(7):695-6. PubMed ID: 17621277 [No Abstract] [Full Text] [Related]
51. Beyond silencing--engineering applications of RNA interference and antisense technology for altering cellular phenotype. Hebert CG; Valdes JJ; Bentley WE Curr Opin Biotechnol; 2008 Oct; 19(5):500-5. PubMed ID: 18760358 [TBL] [Abstract][Full Text] [Related]
59. Attitudes, values, and socio-demographic characteristics that predict acceptance of genetic engineering and applications of new technology in Australia. Mohr P; Harrison A; Wilson C; Baghurst KI; Syrette J Biotechnol J; 2007 Sep; 2(9):1169-78. PubMed ID: 17703489 [TBL] [Abstract][Full Text] [Related]